Case Study
Building a Future-Proof Clinical Data Infrastructure How elluminate Transformed Data Operations for Jazz Pharmaceuticals
PROJECT BACKGROUND Jazz Pharmaceuticals saw the need to evolve its clinical data infrastructure to support its future growth trajectory. To meet the data requirements of current and future studies they knew they needed to establish a new data culture. This vision meant moving on from inefficient, resource-intensive legacy processes to a more intuitive, modern, flexible, and technologydriven approach to clinical data management and clinical analytics.
COMPANY PROFILE ■
Global, Mid-sized BioPharma
■
~ $3.8 Billion+ in Revenue
■
~ 2,800+ Employees
PRODUCTS ■
Mapper
■
Clinical Analytics
■
Data Central
■
Risk-based Quality Management (RBQM)
THE CHALLENGE In the context of their rapid growth, Jazz Pharmaceuticals developed a clear vision of what they required from a new clinical data and analytics platform that would serve as a central hub for all R&D functions who regularly interact with clinical data during a trial. At heart was the need for a robust clinical data strategy that would give them control of their data, oversight into trial and portfolio performance, and efficiencies gained through process improvements and task automation. To
enable their future growth, the solution must stay resilient to changes in their operating model and establish a solid foundation for applications of advanced analytics. To achieve this, they needed a solution that would deliver near real-time insights from the data, scalability to rapidly develop new data deliverables, and flexibility to innovate and accommodate yetunknown future needs.